Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Frankfurt - Delayed Quote EUR

ICU Medical, Inc. (IC7.F)

Compare
126.00
+2.00
+(1.61%)
As of 8:20:03 AM GMT+2. Market Open.

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Mr. Vivek Jain CEO & Chairman of the Board 1.15M 6.91M 1972
Mr. Daniel Woolson President 498.9k -- 1978
Mr. Brian Michael Bonnell CFO & Treasurer 628.69k -- 1974
Mr. Christian B. Voigtlander Chief Operating Officer 638.7k -- 1968
Ms. Virginia Ruth Sanzone Corporate VP, General Counsel, Secretary & Compliance Officer 570.56k -- 1975

ICU Medical, Inc.

951 Calle Amanecer
San Clemente, CA 92673
United States
949 366 2183 https://www.icumed.com
Sector: 
Healthcare
Full Time Employees: 
15,000

Description

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. It offers infusion therapy products, such as needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

Corporate Governance

ICU Medical, Inc.’s ISS Governance QualityScore as of April 1, 2025 is 4. The pillar scores are Audit: 2; Board: 4; Shareholder Rights: 6; Compensation: 4.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 5, 2025 at 8:00 PM UTC - May 9, 2025 at 8:00 PM UTC

ICU Medical, Inc. Earnings Date

Recent Events